Validus (VR) Stock Rating Lowered by Buckingham Research

Validus (NYSE:VR) was downgraded by analysts at Buckingham Research from a “buy” rating to a “neutral” rating in a report issued on Tuesday, The Fly reports.

Several other equities research analysts also recently weighed in on VR. JMP Securities downgraded Validus from an “outperform” rating to a “market perform” rating in a report on Tuesday, January 30th. UBS Group upped their price target on Validus from $48.00 to $52.00 and gave the stock a “neutral” rating in a report on Monday, October 30th. Keefe, Bruyette & Woods downgraded Validus from an “outperform” rating to a “market perform” rating in a report on Monday, January 22nd. ValuEngine upgraded Validus from a “sell” rating to a “hold” rating in a report on Friday, October 20th. Finally, Barclays dropped their price objective on Validus from $57.00 to $53.00 and set an “equal weight” rating on the stock in a report on Monday, October 16th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and one has assigned a buy rating to the stock. Validus presently has an average rating of “Hold” and an average target price of $52.80.

Shares of Validus (NYSE VR) opened at $67.47 on Tuesday. The company has a current ratio of 0.95, a quick ratio of 0.95 and a debt-to-equity ratio of 0.52. Validus has a 1-year low of $41.15 and a 1-year high of $67.73. The firm has a market capitalization of $5,510.36, a PE ratio of -78.45, a price-to-earnings-growth ratio of 1.81 and a beta of 1.05.

Validus (NYSE:VR) last issued its quarterly earnings results on Thursday, February 1st. The insurance provider reported $0.05 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.05 by ($1.00). Validus had a negative return on equity of 1.79% and a negative net margin of 1.70%. The company had revenue of $346.88 million for the quarter, compared to analysts’ expectations of $352.00 million. During the same quarter last year, the company earned $0.80 EPS. Validus’s revenue for the quarter was up 16.1% compared to the same quarter last year. equities analysts expect that Validus will post 4.13 earnings per share for the current year.

In other news, President Kean Driscoll sold 6,875 shares of the stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $46.16, for a total value of $317,350.00. Following the transaction, the president now owns 110,858 shares in the company, valued at approximately $5,117,205.28. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In the last quarter, insiders sold 20,625 shares of company stock worth $984,775. Company insiders own 2.33% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Zions Bancorporation acquired a new stake in shares of Validus in the 3rd quarter valued at about $116,000. The Manufacturers Life Insurance Company boosted its position in shares of Validus by 10.1% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 2,382 shares of the insurance provider’s stock valued at $124,000 after purchasing an additional 219 shares during the period. Advisors Asset Management Inc. boosted its position in shares of Validus by 4,598.8% in the 3rd quarter. Advisors Asset Management Inc. now owns 3,947 shares of the insurance provider’s stock valued at $194,000 after purchasing an additional 3,863 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Validus by 48.5% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,315 shares of the insurance provider’s stock valued at $202,000 after purchasing an additional 1,410 shares during the period. Finally, Paragon Capital Management Ltd acquired a new stake in shares of Validus in the 4th quarter valued at about $211,000. 95.50% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: This news story was first posted by American Banking News and is the property of of American Banking News. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States & international copyright & trademark legislation. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2018/02/13/validus-vr-stock-rating-lowered-by-buckingham-research.html.

About Validus

Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.

The Fly

Analyst Recommendations for Validus (NYSE:VR)

Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply